Retractable Technologies Inc Dossier
Qualitative Analysis
Business overview
Retractable Technologies, Inc. (NYSE American: RVP) designs, develops, manufactures, and markets safety medical products for the healthcare profession. The company's primary product lines include VanishPoint safety syringes, VanishPoint insulin syringes, EasyPoint needles, Patient Safe syringes, and VanishPoint blood collection sets. These products are designed to prevent needlestick injuries and reduce the risk of cross-contamination. Retractable Technologies operates manufacturing facilities in Little Elm, Texas, and utilizes contract manufacturers in China to source a significant portion of its product volume.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
In April 2026, Retractable Technologies announced a workforce reduction of approximately 16% (about 36 positions), primarily affecting manufacturing, manufacturing support, sales, and support roles.
Expected impact: Expected to reduce annual operating expenses and overhead by approximately $2.2 million.
Shifting manufacturing of key product lines (including 1 mL, 3 mL, and EasyPoint products) to its domestic facility in Little Elm, Texas, to mitigate the financial impact of the 120% tariff on Chinese imports.
Expected impact: Reduces reliance on Chinese manufacturers (which supplied 62.6% of products in 2025) and lowers tariff expenses, which were reduced to less than $12,000 in Q1 2026.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
In November 2025, Retractable's EasyPoint Blood Collection Tube Holder with Needle received an Innovative Technology designation from Vizient, the largest healthcare performance improvement company in the U.S., facilitating broader clinical adoption.
Terms: Terms of the GPO contract and pricing agreements are confidential.